The the most comprehensive and authoritative review of these practices was conducted in the United Kingdom by Dr. Hilary Cass. Her 2024 Cass review concluded that the scientific evidence supporting such interventions is remarkably weak. There is no strong long term evidence showing that puberty blockers and transgender surgeries improve long term mental or physical health outcomes for minors. Nor is there robust data on their safety or impact on development. In the United States, the Department of Health and Human Services last month released a peer reviewed report titled Treatment for Pediatric Gender Dysphoria. (01:32–01:42)
CLAIM
Asserts lack of strong evidence for long-term benefits of puberty blockers and surgeries for minors.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
